Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series

BACKGROUND: Intravenous (IV) zanamivir could be a suitable alternative for the treatment of severe influenza A(H1N1)pdm09 infection in patients who are unable to take oral or inhaled medication, for example, those on mechanical ventilation and extracorporeal membrane oxygenation (ECMO). However, dat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Infect Dis
Auteurs principaux: Torti, Carlo, Mazzitelli, Maria, Longhini, Federico, Garofalo, Eugenio, Bruni, Andrea, Giancotti, Aida, Barreca, Giorgio Settimo, Quirino, Angela, Liberto, Maria Carla, Serapide, Francesca, Matera, Giovanni, Trecarichi, Enrico Maria, Navalesi, Paolo
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796355/
https://ncbi.nlm.nih.gov/pubmed/31619209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-019-4530-1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires